ABT-263 A substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying. It is a type of Bcl-2 family inhibitor. Also called navitoclax.
WikiMD Resources - ABT-263
Latest research (Pubmed)
Join WikiMD as a freelancer or paid editor and help improve the page ABT-263 or others.